Marker Therapeutics Inc (MRKR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3200 SOUTHWEST FREEWAY HOUSTON, TX 77027

TapImmune is a biotechnology company whose strategic vision is to develop and market products specializing in the application of the discoveries in cellular and molecular immunology and cancer biology to the development of proprietary therapeutics aimed at the treatment and eradication of cancer and prevention of infectious diseases. Co. is conducting preclinical studies using its TAP gene technology in combination with an in-licensed adeno virus, with the aim of completing its preclinical trials and filing an Investigational Drug Application for cancer in 12 to 24 months.

Data as of 2021-05-08 11:21:08 -0400
Market Cap195.083 Million Shares Outstanding83.014 Million Avg 30-day Volume1.866 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-4.09 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.19454 52-week High/Low3.77 / 1.32 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MRKR instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 60 58 3.45% 17 (1.02%) 13 (0.81%) 30.77%
13F shares: 14.079 Million 14.127 Million -0.34% 3.575 Million 3.4 Million 5.15%
% Ownership 29.3154 29.4167 -0.34% 7.4435 7.0792 5.15%
New Positions: 8 5 60.0% 4 1 300.0%
Increased Positions 17 14 21.43% 4 6 -33.33%
Closed Positions 6 10 -40.0% 2
Reduced Positions 16 17 -5.88% 5 4 25.0%
Total Calls 56.3 Thousand 58.4 Thousand -3.6% 33.6 Thousand 27.6 Thousand 21.74%
Total Puts 0 0
PUT/CALL Ratio 0.0 0.0 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MRKR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRKR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

60.7 Million total shares from 14 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOANG PETER L. PRESIDENT AND CEO

  • Officer
  • Director
332,568 2021-03-16 2

BEHBAHANI ALI

  • 10% Owner
10,714,285 2021-03-16 1

BASKETT FOREST

  • 10% Owner
10,714,285 2021-03-16 1

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
10,714,285 2021-03-16 1

MAKOWER JOSHUA

  • 10% Owner
10,714,285 2021-03-16 1

MAKHZOUMI MOHAMAD

  • 10% Owner
10,714,285 2021-03-16 1

FLORENCE ANTHONY A. JR.

  • 10% Owner
10,714,285 2021-03-16 1

CHANG CARMEN

  • 10% Owner
10,714,285 2021-03-16 1

WALKER PAUL EDWARD

  • 10% Owner
10,714,285 2021-03-16 1

SONSINI PETER W.

  • 10% Owner
10,714,285 2021-03-16 1

SANDELL SCOTT D

  • 10% Owner
10,714,285 2021-03-16 1

VERA JUAN CHIEF DEVELOPMENT OFFICER

  • Officer
2,564,487 2021-03-16 2

WILSON JOHN ROBERT

  • Director
7,799,350 2021-03-16 2

ELMS STEVE

  • Director
3,159,879 2021-03-16 2

LOIACONO MICHAEL CHIEF ACCOUNTING OFFICER

  • Officer
0 2021-02-10 1

KIM ANTHONY H. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-10 1

HOANG TSVETELINA P VP, RESEARCH AND DEVELOPMENT

  • Officer
0 2021-02-10 1

KONERU MYTHILI CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-10 1

AGOPYAN NADIA VP, REGULATORY AFFAIRS

  • Officer
0 2021-02-10 1

GARRETT GERALD VICE PRESIDENT, CLINICAL OPS.

  • Officer
0 2021-02-10 1

SZYMANSKA ANNA VICE PRESIDENT, QUALITY

  • Officer
0 2021-02-10 1

LASKOW-POOLEY DAVID

  • Director
42,565 2020-12-31 1

WASSERMAN FREDERICK GERALD

  • Director
42,565 2020-12-31 1

EANSOR NORMAN DAVID

  • Director
24,282 2020-12-31 1

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
4,050,001 2020-11-09 2

LEEN ANN M. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-15 0

MOSELEY KEN GENERAL COUNSEL

  • Officer
0 2018-12-21 0

BARRIS PETER J

  • 10% Owner
5,000,000 2018-10-17 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

MOTT DAVID M

  • 10% Owner
5,000,000 2018-10-17 0

REDDISH MARK

  • Director
No longer subject to file 2018-10-16 0

GRISEWOOD SHERRY

  • Director
No longer subject to file 2018-10-16 0

SILVERMAN JOSHUA

  • Director
No longer subject to file 2018-10-16 0

WILSON GLYNN

  • Director
181,776 2018-10-09 0

BONFIGLIO JOHN N PRESIDENT AND COO

  • Officer
  • Director
36,471 2017-03-09 0

CORIN DENIS PRESIDENT AND CFO

  • Officer
  • Director
2,363,168 2011-03-23 0

DEPIPPO LYNN

  • Director
108,696 2010-09-07 0

MOORE TRACY A CHIEF FINANCIAL OFFICER

  • Officer
  • Director
500,000 2009-10-14 0

LINDSAY ALAN P

  • Director
0 2009-03-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ELMS STEVE - Director see footnote

2021-03-18 16:35:34 -0400 2021-03-16 P 1,142,857 $1.75 a 3,142,857 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

SANDELL SCOTT D - > 10% Owner see note 1

2021-03-18 17:17:11 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

FLORENCE ANTHONY A. JR. - > 10% Owner see note 1

2021-03-18 17:14:03 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

BASKETT FOREST - > 10% Owner see note 1

2021-03-18 17:09:53 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

VERA JUAN - Officer CHIEF DEVELOPMENT OFFICER

2021-03-18 16:38:07 -0400 2021-03-16 P 571,428 $1.75 a 2,564,487 direct 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

SONSINI PETER W. - > 10% Owner see note 1

2021-03-18 17:17:55 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

MAKOWER JOSHUA - > 10% Owner see note 1

2021-03-18 17:16:26 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

CHANG CARMEN - > 10% Owner see note 1

2021-03-18 17:12:44 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

NEW ENTERPRISE ASSOCIATES 16, L.P. - > 10% Owner

NEA PARTNERS 16, L.P. - > 10% Owner

NEA 16 GP, LLC - > 10% Owner

2021-03-18 17:08:23 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 direct 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

HOANG PETER L. - Director - Officer PRESIDENT AND CEO

2021-03-18 16:36:47 -0400 2021-03-16 P 142,857 $1.75 a 332,568 direct 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

WALKER PAUL EDWARD - > 10% Owner see note 1

2021-03-18 17:18:33 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

MAKHZOUMI MOHAMAD - > 10% Owner see note 1

2021-03-18 17:15:24 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

BEHBAHANI ALI - > 10% Owner see note 1

2021-03-18 17:11:40 -0400 2021-03-16 P 5,714,285 $1.75 a 10,714,285 indirect 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

WILSON JOHN ROBERT - Director

2021-03-18 16:39:16 -0400 2021-03-16 P 1,714,285 $1.75 a 7,799,350 direct 18.1818 -2.8926 4.1322 18.1818 2 -22.314 22

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MARKER THERAPEUTICS INC MRKR 2021-05-10 22:15:04 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 21:45:02 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 21:15:02 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 20:45:03 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 20:15:03 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 19:45:03 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 19:15:03 UTC -4.6178 4.6678 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 18:45:03 UTC -4.632 4.682 650000
MARKER THERAPEUTICS INC MRKR 2021-05-10 18:15:03 UTC -4.632 4.682 700000
MARKER THERAPEUTICS INC MRKR 2021-05-10 17:45:02 UTC -4.632 4.682 700000
MARKER THERAPEUTICS INC MRKR 2021-05-10 17:15:03 UTC -4.632 4.682 700000
MARKER THERAPEUTICS INC MRKR 2021-05-10 16:45:03 UTC -4.632 4.682 700000
MARKER THERAPEUTICS INC MRKR 2021-05-10 16:15:03 UTC -4.632 4.682 700000
MARKER THERAPEUTICS INC MRKR 2021-05-10 15:45:03 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 15:15:03 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 14:45:04 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 14:15:04 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 13:45:04 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 13:15:03 UTC -4.632 4.682 500000
MARKER THERAPEUTICS INC MRKR 2021-05-10 12:45:02 UTC -4.632 4.682 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments